XML 49 R40.htm IDEA: XBRL DOCUMENT v3.22.2.2
Nature of Operations and Summary of Significant Accounting Policies (Details) - USD ($)
3 Months Ended 9 Months Ended 21 Months Ended
Aug. 05, 2022
Sep. 30, 2022
Jun. 30, 2022
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Jun. 13, 2022
Apr. 28, 2022
Dec. 31, 2021
Jan. 01, 2021
Dec. 31, 2020
Product Warranty Liability [Line Items]                      
Assets   $ 138,481,000   $ 138,481,000   $ 138,481,000     $ 169,175,000    
Cash, cash equivalents and restricted cash   51,047,000   51,047,000 $ 144,719,000 51,047,000     105,692,000   $ 121,853,000
Liabilities   226,820,000   226,820,000   226,820,000     136,728,000    
Convertible notes payable   78,743,000   78,743,000   78,743,000          
Other long-term debt   84,775,000   84,775,000   84,775,000          
Accumulated deficit   (589,727,000)   (589,727,000)   (589,727,000)     (416,527,000)    
Net cash used in operating activities       (159,129,000) (80,605,000)            
Proceeds received from the Term Loan, net of discount       92,783,000 0            
Proceeds from equipment financing facility       4,216,000 7,000,000            
Operating lease right-of-use asset, net   4,546,000   4,546,000   4,546,000     $ 3,468,000 $ 3,662,000  
Present value of minimum lease payments   5,493,000   5,493,000   5,493,000       $ 4,465,000  
ATM                      
Product Warranty Liability [Line Items]                      
Authorized value of stock to be sold $ 100,000,000 $ 100,000,000   100,000,000   $ 100,000,000          
Commission on gross sale proceeds 3.00% 3.00%                  
Sale of stock, number of shares issued in transaction (in shares)   12,067,575                  
Issuance of common stock   $ 30,040,000   $ 29,139,000 0            
Cash received on issuance of shares   $ 29,139,000                  
Sale of stock, price per share (in dollars per share)   $ 2.49   $ 2.49   $ 2.49          
Private Placement                      
Product Warranty Liability [Line Items]                      
Authorized value of stock to be sold     $ 200,000,000       $ 200,000,000 $ 200,000,000      
Sale of stock, number of shares issued in transaction (in shares)   3,967,939   3,967,939              
Issuance of common stock       $ 5,000,000 0            
Cash received on issuance of shares   $ 5,000,000   $ 5,000,000              
Sale of stock, price per share (in dollars per share)   $ 1.26   $ 1.26   $ 1.26          
Agreement term     2 years                
Share price as percentage of market price     97.00%         97.00%      
Proceeds from sale of treasury stock   $ 12,500,000                  
Term Loan Agreement | Secured Debt                      
Product Warranty Liability [Line Items]                      
Proceeds received from the Term Loan, net of discount   94,681,000                  
Equipment financing facility | Line of Credit                      
Product Warranty Liability [Line Items]                      
Proceeds from equipment financing facility   $ 4,216,000   $ 4,216,000 $ 7,000,000 $ 11,216,000